연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1224 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial | Rugo, Hope S. | Rugo, HS | 19 | Univ Calif San Francisco, San Francisco, CA USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial | Liyanage, Marlon | Liyanage, M | 20 | Pfizer, San Diego, CA USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial | Saul, Michelle | Saul, M | 21 | Pfizer, San Diego, CA USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial | Le Corre, Christophe | Le Corre, C | 22 | Pfizer, San Diego, CA USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial | Skoura, Athanasia | Skoura, A | 23 | Pfizer, Collegeville, PA USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial | Liu, Li | Liu, L | 24 | Pfizer, San Diego, CA USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial | Li, Meng | Li, M | 25 | 교신저자 | Pfizer, San Francisco, CA 94080 USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | ||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial | LoRusso, Patricia M. | LoRusso, PM | 26 | 교신저자 | Yale Sch Med, New Haven, CT 06510 USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | ||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Mukohara, Toru | Mukohara, T | 1 | Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Park, Yeon Hee | Park, YH | 2 | Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Sommerhalder, David | Sommerhalder, D | 3 | NEXT Oncol, San Antonio, TX USA | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Yonemori, Kan | Yonemori, K | 4 | Natl Canc Ctr, Tokyo, Japan | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Hamilton, Erika | Hamilton, E | 5 | Sarah Cannon Res Inst, Nashville, TN USA | 0000-0002-1911-0336 | Hamilton, Erika | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Kim, Sung-Bae | Kim, SB | 6 | Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea | AAI-3081-2021 | Kim, Sung | meng.li7@pfizer.com;patricia.lorusso@yale.edu; | |||
| Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2⁻ metastatic breast cancer: a phase 1 trial (vol 30, pg 2242, 2024) | Kim, Jee Hyun | Kim, JH | 7 | Seoul Natl Univ, Coll Med, Bundang Hosp, Seongnam, South Korea | F-8777-2012 | Kim, Jee | meng.li7@pfizer.com;patricia.lorusso@yale.edu; |
페이지 이동: